142 related articles for article (PubMed ID: 35462329)
1. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract][Full Text] [Related]
2. LINC00963/miR-4458 regulates the effect of oxaliplatin in gastric cancer by mediating autophagic flux through targeting of ATG16L1.
Hou M; Li C; Dong S
Sci Rep; 2021 Oct; 11(1):20951. PubMed ID: 34697403
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA
Wu Z; Wang W; Wang Y; Wang X; Sun S; Yao Y; Zhang Y; Ren Z
Cell Cycle; 2020 Mar; 19(5):610-624. PubMed ID: 32052688
[TBL] [Abstract][Full Text] [Related]
4. LINC00963 promotes the malignancy and metastasis of lung adenocarcinoma by stabilizing Zeb1 and exosomes-induced M2 macrophage polarization.
Hu R; Xu B; Ma J; Li L; Zhang L; Wang L; Zhu J; Guo T; Zhang H; Wang S
Mol Med; 2023 Jan; 29(1):1. PubMed ID: 36604626
[TBL] [Abstract][Full Text] [Related]
5. LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway.
Wu JH; Tian XY; An QM; Guan XY; Hao CY
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1645-1652. PubMed ID: 29630107
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer.
Sun F; Wu K; Yao Z; Mu X; Zheng Z; Sun M; Wang Y; Liu Z; Zhu Y
Aging (Albany NY); 2020 Jun; 12(12):11500-11516. PubMed ID: 32554858
[TBL] [Abstract][Full Text] [Related]
7. EZH2-mediated long-chain non-coding RNA LINC00963 promotes proliferation and invasion of glioma cells through inhibiting p21 expression.
Gai Q; Guo W; Liu J
J BUON; 2021; 26(2):380-387. PubMed ID: 34076983
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of LINC00461 in cancer.
Zhang Q; Zhong C; Shen J; Chen S; Jia Y; Duan S
Biomed Pharmacother; 2022 Aug; 152():113239. PubMed ID: 35679722
[TBL] [Abstract][Full Text] [Related]
9. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
11. LINC00958: A promising long non-coding RNA related to cancer.
Li H; Gao J; Liu L; Zhang S
Biomed Pharmacother; 2022 Jul; 151():113087. PubMed ID: 35569349
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of LINC00963 facilitates melanoma progression through miR-608/NACC1 pathway and predicts poor prognosis.
Jiao H; Jiang S; Wang H; Li Y; Zhang W
Biochem Biophys Res Commun; 2018 Sep; 504(1):34-39. PubMed ID: 30180950
[TBL] [Abstract][Full Text] [Related]
14. The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis.
Zhou Y; Yin L; Li H; Liu LH; Xiao T
Cancer Biol Ther; 2019; 20(8):1141-1148. PubMed ID: 30975024
[No Abstract] [Full Text] [Related]
15. LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.
Zhong C; Xie Z; Shen J; Jia Y; Duan S
Cells; 2022 May; 11(9):. PubMed ID: 35563845
[TBL] [Abstract][Full Text] [Related]
16. LINC00963 predicts poor prognosis and promotes esophageal cancer cells invasion via targeting miR-214-5p/RAB14 axis.
Liu HF; Zhen Q; Fan YK
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):164-173. PubMed ID: 31957829
[TBL] [Abstract][Full Text] [Related]
17. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
[TBL] [Abstract][Full Text] [Related]
18. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis.
Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
Front Immunol; 2022; 13():855078. PubMed ID: 35784328
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
[TBL] [Abstract][Full Text] [Related]
20. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway.
Yu T; Zhao Y; Hu Z; Li J; Chu D; Zhang J; Li Z; Chen B; Zhang X; Pan H; Li S; Lin H; Liu L; Yan M; He X; Yao M
Cancer Res; 2017 Nov; 77(21):5782-5794. PubMed ID: 28923857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
